Author

A. L. Vishwakarma

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

A. K. Singh· 1 shared A. Singh· 1 shared A. Verma· 1 shared D. Datta· 1 shared J. Sarkar· 1 shared K. K. Saini· 1 shared K. Singh· 1 shared M. A. Nengroo· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. K. Singh

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Salinomycin inhibits epigenetic modulator EZH2 to enhance Death Receptors in Colon Cancer Stem Cells

A. K. Singh, A. Verma, A. Singh, R. K. Arya, S. Maheshwari, P. Chaturvedi, M. A. Nengroo, K. K. Saini, A. L. Vishwakarma, K. Singh, J. Sarkar, D. Datta

This study shows salinomycin inhibits EZH2 in colon CSCs, enhancing DR4/DR5 expression and reducing CSC traits, suggesting a therapeutic strategy combining TRAIL and EZH2 inhibitors.

bioRxiv · Feb 3, 2020Cancer Biology